MissionIR Articles

Bright Future for LTO Tape Tech, QBAK a Sector Pioneer N2Power Upside Bullish Amid Burgeoning Gaming Market 12 Months of Positive Cash Flow, Solid Long-Term Fundamentals Qualstar is one of the oldest names in data…

Oncology pipeline features significant safety/efficacy advantages Lead candidate poised for FDA acceleration due to significant unmet need in AML Broad-spectrum applicability of WP1066 & WP1122 portfolios of molecules For preclinical oncology biopharma Moleculin Biotech, Inc.…

With more than a century of combined experience spanning the gamut from pancreas/GI tract issues in hepato-gastroenterology and infectious disease to the development of novel non-systemic (localized) therapeutic biologics and proteomics (protein engineering), the AzurRx…

FORM Holdings (NASDAQ: FH) employs a relatively simple yet extremely robust targeting matrix when it comes to acquiring new development candidates. It’s really all about what this diverse holding company can bring to table, as…

The Female Health Company / Veru Healthcare (NASDAQ:FHCO) has established for itself an extremely robust footing in the global public health sector via its hormone-free, latex-free FC2 Female Condom, the only FDA-approved female condom in…

Revance Therapeutics, Inc. (NASDAQ: RVNC), a biotechnology company focused on the development, commercialization, and manufacture of botulinum toxin products for use in aesthetic and therapeutic indications, including dermatology and neurology, recently announced its operating results…

The Trade Desk, Inc. (NASDAQ: TTD) is a technology company that allows buyers to use proprietary data to better target their advertising dollars. With The Trade Desk platform, organizations are able to use fully automated…

Daktronics, Inc. (NASDAQ: DAKT), a company that designs, manufactures, and sells electronic display systems and related products on a global scale, has been the topic of several reports since the company announced breaking into a…

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) is a biotechnology company focused on the development of generic versions of complex drugs. The company is in the business of discovering and developing new therapies for oncology and autoimmune…

Matinas BioPharma Holdings, Inc. (OTCQB: MTNB), is a biopharmaceutical company still in its clinical stages, focused on identifying and developing treatments for fungal and bacterial infections. Founded in 2012, the company’s goal is to change…

According to a past article on MarketWatch (http://dtn.fm/ruK1O), after the Fukushima nuclear disaster there was an increase in liquefied natural gas (LNG) demand in 2012. This meant that the LNG carrier fleet was operating at…

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical stage drug development company targeting rare, chronic, and serious inflammatory and fibrotic diseases, recently reported its third quarter financial results (http://dtn.fm/R6EgY) for the three months ended September…

ClearOne, Inc. (NASDAQ: CLRO), a company that designs, develops, and commercializes conferencing, collaboration, and network streaming and signage solutions for voice and visual communications, recently announced its quarterly earnings, reporting a $0.22 earnings per share…

Conatus Pharmaceuticals, Inc. (NASDAQ: CNAT), a biotechnology company focused on the development and commercialization of new medicines to treat a variety of liver diseases, recently announced its financial results for the third quarter of 2016…

Distilling complexity into actionable intelligence is the core focus for recently rebranded data analytics outfit Cogint, Inc. (NASDAQ: COGT). Cogint rang the NASDAQ bell (http://dtn.fm/OTm74) only a handful of days after transitioning shares over to…

November has been a promising month for CytoSorbents Corp. (NASDAQ: CTSO), a critical care immunotherapy company. The New Jersey-based company, specializing in blood purification to control deadly inflammation in critically ill and cardiac surgery patients,…

Nektar Therapeutics (NASDAQ: NKTR), a biopharmaceutical company in the business of developing new medicines for people living with life changing conditions, now helps more than nine million patients worldwide. Nektar also offers a proprietary pipeline…

Trevena, Inc. (NASDAQ: TRVN) is a clinical stage biopharmaceutical company focused on developing and delivering biased ligands to discover the next generation of GPCR targeted medicine. The company is focused on three product candidates: Oliceridine,…

Last month, Celldex Therapeutics, Inc. (NASDAQ: CLDX), a company in the business of developing targeted therapeutics for those suffering from devastating diseases for which current treatments are inadequate, found positive results from its phase II…

Fibrosis is when connective tissue from an injury or other circumstances thickens and scars, or when there is excess fibrous connective tissue in an organ after it has been exposed to a chronic disease. Unfortunately,…